Balanced Portfolio Recommendation: Trim Neuren Pharmaceuticals (NEU)
After much higher than expected sales results, we recommend a trim of 1% (one quarter) of the holding
November 2023
Pre-Market Pulse 3rd November – Stocks bounce as investors call the peak in rates….again
Stocks were in a rally mode Thursday, buoyed by a slump in Treasury yields on bets that the Federal Reserve is done raising interest rates after holding its benchmark rate steady for the second meeting in a row.
Closing Bell 2nd November: Uncertainty Looms Despite ASX Gains, as Future Rate Hikes Remain Possible
Jerome Powell’s words echo across global markets, with ASX sectors reacting to potential future rate adjustments.
Pre-Market Pulse 2nd November – Stocks get relief rally as Fed keeps rates unchanged
Equities ended higher overnight following a slump in Treasury yields after the Federal Reserve kept rates steady for second-straight meeting.
Closing Bell 1st November: Miners Shine as Banks Soften and Investors Eye Federal Reserve’s Next Move
ASX sees a glimmer of recovery, echoing Wall Street’s optimism. Mining giants like Rio Tinto and Fortescue light up the market with notable gains. vestors hold their breath, awaiting insights from the Federal Reserve policy statement.
Balanced Portfolio Recommendation: BUY – Paladin Energy (PDN)
Recent earnings results from Canadian uranium-fuel giant, Cameco saw a significant increase in nuclear energy demand and a potential supply gap in the immediate future. This demand is driven by global calls for clean, secure, and affordable energy with Nuclear being the stop-gap solution for base load electricity until new energy technologies become more commercial
Pre-Market Pulse 1st November – Equities book 3rd consecutive monthly loss despite overnight rally
Equities ground higher overnight, led by big tech, ahead of the earnings from Apple later this week, and the Federal Reserve’s interest rate decision due Wednesday.